Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting

Current antiangiogenic immunotherapeutic strategies mainly focus on the blockade of circulating cytokines or receptors that are overexpressed by endothelial cells. We proposed globotriaosylceramide (Gb3) as a viable alternative target for antiangiogenic therapies. In this setting, we developed an an...

Descripción completa

Detalles Bibliográficos
Autores principales: Birklé, Stéphane, Desselle, Ariane, Chaumette, Tanguy, Gaugler, Marie-Hélène, Cochonneau, Denis, Fleurence, Julien, Dubois, Nolwenn, Hulin, Philippe, Aubry, Jacques, Paris, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654593/
https://www.ncbi.nlm.nih.gov/pubmed/23734323
http://dx.doi.org/10.4161/onci.23700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654593/
https://www.ncbi.nlm.nih.gov/pubmed/23734323
http://dx.doi.org/10.4161/onci.23700

Ejemplares similares